Isolation of three separate anaphylatoxins from complement-activated human serum

Area of Science:

• Immunology
• Biochemistry

Background:

• Anaphylatoxins (C3a, C4a, C5a) are key mediators in immune responses.
• Generating all three anaphylatoxins simultaneously from human serum is challenging.
• Serum carboxypeptidase N (SCPN) degrades these anaphylatoxins, complicating purification.

Purpose of the Study:

• To describe a method for simultaneous generation of C3a, C4a, and C5a from human serum.
• To introduce novel inhibitors for serum carboxypeptidase N (SCPN).
• To outline a procedure for isolating homogeneous anaphylatoxins.

Main Methods:

• Complement activation via a novel scheme to generate C3a, C4a, and C5a.
• Utilizing new mercapto derivatives of arginine analogs as potent SCPN inhibitors.
• Purification of intact anaphylatoxins from complement-activated serum.

Main Results:

• Successful simultaneous generation of all three anaphylatoxins (C3a, C4a, C5a) in human serum.
• New SCPN inhibitors are effective at millimolar (mM) concentrations, unlike previous inhibitors requiring molar (M) concentrations.
• These inhibitors allow normal complement activation while preventing anaphylatoxin degradation.

Conclusions:

• The described method enables efficient generation and isolation of all three major anaphylatoxins.
• Novel SCPN inhibitors offer a significant improvement over existing methods for anaphylatoxin purification.
• This advancement facilitates further research into the roles of anaphylatoxins in biological systems.